Sage Journals: Discover world-class research

Abstract

Currently, the detection of renal vascular lesions (VLS) in lupus nephritis (LN) mainly depends on biopsy examination, and lack surrogate biomarkers for clinical dynamic evaluation. The aim of the present study is to explore the correlation between circulatory endothelial damage biomarkers and VLS. Soluble E-selectin, thrombomodulin (TM) and vascular cell adhesion molecule-1 (VCAM-1) were measured by ELISA. TM and VCAM-1 levels both were significantly elevated in LN with VLS than in LN without VLS (P < 0.01). However, the serum E-selectin was not significantly changed in LN patients with and without VLS. A positive correlation was found between TM and serum creatinine (r = 0.617, P < 0.05) in patients with vascular lesions. In order to further analyse the relationship between TM level and severity degree of vascular lesions in LN patients, we subdivided the patients with vascular lesions into two groups: with thrombotic microangiopathy (TMA) and without TMA. TM level of the patients with TMA is significantly higher than those without TMA (P < 0.01). In conclusion, combined with renal pathological examination, monitoring the circulatory levels of TM and VCAM-1, can provide circulating biomarkers of VLS in LN patients.

Keywords

lupus nephritis vascular lesion thrombomodulin vascular cell adhesion molecule-1 E-selectin

Get full access to this article

View all access options for this article.

References

1 Mok CC . Prognostic factors in lupus nephritis. Lupus 2005; 14: 39 – 44 .

2 Banfi G Bertani T Boeri V . Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991; 18: 240 – 248 .

3 Appel GB Pirani CL D’Agall V . Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 1994; 4: 1499 – 1515 .

4 Chong AY Blann AD Lip GYH . Assessment of endothelial damage and dysfunction: observations in relation to heart failure. Q J Med 2003; 96: 253 – 267 .

5 Kiraz S Ertenli I Benekli M . Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state. Lupus 1999; 8: 737 – 741 .

6 Ohdama S Takano S Miyake S Kubota T Sato K Aoki N . Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. J Clin Pathol 1994; 101: 109 – 113 .

7 Wada H Ohiwa M Kaneko T . Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 1992; 39: 20 – 24 .

8 Ho CY Wong CK Li EK Tam LS Lam CWK . Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesiong molecule-1 in patients with systemic lupus erythematosus. Rheumatology 2003; 42: 117 – 122 .

9 Lai KN Leung JCK Lai KB Wong KC Lai CKW . Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 1996; 81: 229 – 238 .

10.

10 Di Lorenzo G Pacor ML Mansueto P . Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis. J Nephrol 2004; 17: 800 – 807 .

11.

11 Hochberg MC . Updating the American College of Rheumatology revised criteria for classifications of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725 – 1726 .

12.

12 Weening JJ . D’Agati, D, Schwartz, M, et al. The classification of glomerulonephritis in systemic lupus erythematosus. Kidney Int 2004; 65: 521 – 530 .

13.

13 Bombardier C Gladman DD Urowitz MB Caron D Chang CH . Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630 – 640 .

14.

14 Boehme MWJ Nawroth PP Kling E . Serum thrombomodulin: a novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 572 – 577 .

15.

15 Frijns R Fijnheer R Schiel A Donders R Sixma J Derksen R . Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers. J Rheumatol 2001; 28: 514 – 519 .

16.

16 Rustom R Leggat H Tomura HR Hay CR Bone JM . Plasma thrombomodulin in renal disease: effects of renal function and proteinuria. Clin Nephrol 1998; 50: 337 – 341 .

17.

17 Hergesell O Andrassy K Geberth S Nawroth P Gabath S . Plasma thrombomodulin levels are dependent on renal function. Thromb Res 1993; 72: 455 – 458 .

18.

18 Tesar V Masek Z Rychilk I . Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant 1998; 13: 1662 – 1667 .

19.

19 Blann AD Lip GYH . The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coagul Fibrinolysis 1998; 9: 297 – 306 .

20.

20 Egerer K Feist E Rohr U Pruss A Burmester G-R Dorner T . Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000; 9: 614 – 621 .

21.

21 Nakatani K Fujii H Hasegawa H . Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Kidney Int 2004; 65: 1290 – 1300 .

22.

22 Mrowka C Sieberth HG . Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener’s granulomatosis, systemic lupus erythematosus and chronic renal failure. Clin Nephrol 1995; 43: 288 – 296 .

23.

23 Mrowka C Sieberth HG . Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegner’s granulomatosis and systemic lupus erythematosus. Clin Investig 1994; 72: 762 – 768 .

24.

24 Takaya M Ichikawa Y Kobayashi N . Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1991; 9: 495 – 499 .

25.

25 Tomura S Deguchi F Marumo F . Enhanced presence of thrombomodulin in the glomeruli of lupus glomerulonephritis. Clin Nephrol 1994; 41: 205 – 210 .

Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis

Abstract

Keywords

Get full access to this article

References